A case of revertant mosaic-like normal-looking spots in a patient with erythroderma with IL36RN and CARD14 heterozygous mutations

J Dermatol. 2024 Dec;51(12):1669-1673. doi: 10.1111/1346-8138.17498. Epub 2024 Oct 7.

Abstract

An 89-year-old Japanese woman presented with erythroderma associated with significant scaling. A histological examination showed acanthosis with hyperkeratosis and hyperkeratinization of the hair follicles. Genetic analyses using DNA from the peripheral blood revealed heterozygous mutations in IL36RN (c.115+6T>C) and CARD14 c.2648G>A (p.Arg883His). Based on these findings, we diagnosed her with erythroderma attributable to autoinflammatory keratinization disease. She then developed more than 30 small, round, well-defined, spots on her back and extremities that appeared histologically normal. We suspected that these spots might be revertant mosaicism. Immunohistochemical staining with p65, which is a component of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB), revealed nuclear staining in epidermal keratinocytes in erythematous lesions, but not in the normal-looking spots. However, mutations in IL36RN and CARD14 unexpectedly persisted in the epidermis and dermis of the normal-looking spots.

Keywords: CARD14; IL36RN; autoinflammatory keratinization diseases; erythroderma; revertant mosaicism.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • CARD Signaling Adaptor Proteins* / genetics
  • Dermatitis, Exfoliative* / diagnosis
  • Dermatitis, Exfoliative* / genetics
  • Dermatitis, Exfoliative* / pathology
  • Epidermis / pathology
  • Female
  • Guanylate Cyclase* / genetics
  • Heterozygote*
  • Humans
  • Interleukins* / genetics
  • Keratinocytes / pathology
  • Membrane Proteins* / genetics
  • Mosaicism
  • Mutation
  • Skin / pathology

Substances

  • CARD Signaling Adaptor Proteins
  • IL36RN protein, human
  • CARD14 protein, human
  • Guanylate Cyclase
  • Interleukins
  • Membrane Proteins